Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study
Annals of Pharmacotherapy · 2025
DOI: 10.1177/10600280241255837 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Annals of Pharmacotherapy, 2025. Verfasst von Hayahide Ooi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National Hospital Organization Mie Chuo Medical Center, Tsu, Japan. Hauptthemen laut MEDLINE: Piperacillin, Tazobactam Drug Combination, Anti-Bacterial Agents, Liver, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: japan society for the promotion of science.
Abstract (Originalsprache)
Background
Piperacillin/tazobactam (PIPC/TAZ), which is a combination of a beta-lactam/beta-lactamase inhibitor, often causes liver enzyme abnormalities. The albumin-bilirubin (ALBI) score is a simple index that uses the serum albumin and total bilirubin levels for estimating hepatic functional reserve. Although patients with low hepatic reserve may be at high risk for drug-induced liver enzyme abnormalities, the relationship between PIPC/TAZ-induced abnormal liver enzymes levels and the ALBI score remains unknown.
Objective
This study aimed to elucidate the relationship between PIPC/TAZ-induced abnormal liver enzyme levels and the ALBI score.
Methods
This single-center retrospective case-control study included 335 patients. The primary outcome was PIPC/TAZ-induced abnormal liver enzyme levels. We performed COX regression analysis with male gender, age (≥75 years), alanine aminotransferase level (≥20 IU/L), and ALBI score (≥−2.00) as explanatory factors. To investigate the influence of the ALBI score on the development of abnormal liver enzyme levels, 1:1 propensity score matching between the ≤−2.00 and ≥−2.00 ALBI score groups was performed using the risk factors for drug-induced abnormal liver enzyme levels.
Results
The incidence of abnormal liver enzyme levels was 14.0% (47/335). COX regression analysis revealed that an ALBI score ≥−2.00 was an independent risk factor for PIPC/TAZ-induced abnormal liver enzyme levels (adjusted hazard ratio: 3.08, 95% coefficient interval: 1.207-7.835, P = 0.019). After 1:1 propensity score matching, the Kaplan-Meier curve revealed that the cumulative risk for PIPC/TAZ-induced abnormal liver enzyme levels was significantly higher in the ALBI score ≥−2.00 group (n = 76) than in the
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, National Hospital Organization Mie Chuo Medical Center, Tsu, Japan.
- Department of Pharmacy, Mie University Hospital, Faculty of Medicine, Mie University, Tsu, Japan.
- Graduate School and Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan.
ORCID-Profile: Yuki Asai
Förderung
- japan society for the promotion of science
Zitieren
APA
Ooi, H., Asai, Y., Koriyama, Y., & Takahashi, M. (2025). Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study. Annals of Pharmacotherapy. https://doi.org/10.1177/10600280241255837
Vancouver
Ooi H, Asai Y, Koriyama Y, Takahashi M. Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study. Annals of Pharmacotherapy. 2025. doi:10.1177/10600280241255837
BibTeX
@article{Ooi2025,
author = {Ooi, Hayahide and Asai, Yuki and Koriyama, Yoshiki and Takahashi, Masaaki},
title = {Decreased Hepatic Functional Reserve Increases the Risk of Piperacillin/Tazobactam-Induced Abnormal Liver Enzyme Levels: A Retrospective Case-Control Study},
journal = {Annals of Pharmacotherapy},
year = {2025},
doi = {10.1177/10600280241255837}
}
EUVIMED